Company / PP&E (Net)
Penumbra, Inc. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$117.4M
FY2025
5-year range
$58.9M / $117.4M
FY2021-FY2025
Trend
+87.5%
vs FY2024
Sector context
#77 of 130
Health Care
What the data says
At $117M, Penumbra, Inc.'s pp&e (net) ranks #77 of 130 in the Health Care sector. PP&E (Net) has fluctuated over the past 10 years, ranging from $21M in FY2016 to $117M in FY2025.
Based on SEC 10-K filings.
$117M in FY2025 with a 5-year CAGR of +19.5%.
Improved from $73M to $117M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +21.8%
- 5-Year CAGR
- +19.5%
- 10-Year CAGR
- -
Sector benchmark
#77 of 130 in Health CareTop 59% of 130This company $117.4M Sector average $1.3B
▼
-91.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +19.5%, indicating consistent growth.
- In FY2025, pp&e (net) increased 87.5% year-over-year.
- Ranks #77 out of 130 companies in the Health Care sector.
- Lowest pp&e (net) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.11 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $117.4M | +87.5% |
| FY2024 | $62.6M | -13.8% |
| FY2023 | $72.7M | +11.8% |
| FY2022 | $65.0M | +10.5% |
| FY2021 | $58.9M | +22.2% |
| FY2020 | $48.2M | -7.0% |
| FY2019 | $51.8M | +46.3% |
| FY2018 | $35.4M | +14.6% |
| FY2017 | $30.9M | +44.0% |
| FY2016 | $21.5M | +139.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026